Труды сотрудников КНЦ СО РАН

/ M. L. Ibba, G. Ciccone, G. Condorelli [et al.] // Sib. Med. Rev. - 2022. - Vol. 2022, Is. 5. - P114, DOI 10.20333/25000136-2022-5-114 . - ISSN 1819-9496
Аннотация: This paper describes a novel combined approach to targeting GBM with multiple RNA-based therapeutics. Overall, the results demonstrate the good potential of a smart safe and clinically applicable combined regimen for the treatment of glioblastoma, opening up a new avenue in the treatment of this aggressive disease. © IBBA M. L., CICCONE G., CONDORELLI G., DE FRANCISCIS V., CATUOGNO S., MORYACHKOV R. V., MOROZOV E., ESPOSITO C. L.

Scopus

Держатели документа:
Department of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Naples, 80131, Italy
Istitute for Experimental Endocrinology and Oncology, Research National Council (CNR), Naples, 80145, Italy
Institute of Genetic and Biomedical Research (IRGB), Research National Council (CNR), Milan, Italy
IRCCS Neuromed (Istituto di Ricovero e Cura a Carattere Scientifico Neuromed) Istituto Neurologico Mediterraneo, Pozzilli, 86077, Italy
Federal Research Center “Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences”, Krasnoyarsk, Russian Federation
Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, Russian Federation

Доп.точки доступа:
Ibba, M. L.; Ciccone, G.; Condorelli, G.; Franciscis, V.; Catuogno, S.; Moryachkov, R. V.; Morozov, E. V.; Kuligina, E. V.; Esposito, C. L.